- Report
- May 2026
- 301 Pages
Global
From €2349EUR$2,500USD£1,959GBP
- Report
- September 2026
- 189 Pages
Global
From €3331EUR$3,545USD£2,778GBP
€3701EUR$3,939USD£3,087GBP
- Report
- June 2024
- 200 Pages
Global
From €7469EUR$7,950USD£6,230GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1879EUR$2,000USD£1,567GBP
- Report
- May 2024
- 137 Pages
Global
From €3757EUR$3,999USD£3,134GBP
The Skin Disease Drugs market is a subset of the Dermatological Drugs market, which includes drugs used to treat skin diseases and conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Common treatments include topical creams, ointments, and oral medications. Many of these drugs are available over-the-counter, while others require a prescription from a doctor.
The Skin Disease Drugs market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Pfizer, Novartis, Johnson & Johnson, and Merck. Other companies include Allergan, Sanofi, Bayer, and Mylan. Show Less Read more